Budget Impact Analysis of Diabetes Drugs: A Systematic Literature Review

Background: Budget impact analysis (BIA) is an economic assessment that estimates the financial consequences of adopting a new intervention. BIA is used to make informed reimbursement decisions, as a supplement to cost-effectiveness analyses (CEAs).Objectives: We systematically reviewed BIA studies...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Zejun Luo, Zhen Ruan, Dongning Yao, Carolina Oi Lam Ung, Yunfeng Lai, Hao Hu
Formato:	article
Lenguaje:	EN
Publicado:	Frontiers Media S.A. 2021
Materias:	budget impact analysis diabetes cost-effectiveness BIA CEA Public aspects of medicine RA1-1270
Acceso en línea:	https://doaj.org/article/a0af68f6f1624bf5ba2cdb9e929b7fb9
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:a0af68f6f1624bf5ba2cdb9e929b7fb9
record_format	dspace
spelling	oai:doaj.org-article:a0af68f6f1624bf5ba2cdb9e929b7fb92021-11-19T04:52:26ZBudget Impact Analysis of Diabetes Drugs: A Systematic Literature Review2296-256510.3389/fpubh.2021.765999https://doaj.org/article/a0af68f6f1624bf5ba2cdb9e929b7fb92021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fpubh.2021.765999/fullhttps://doaj.org/toc/2296-2565Background: Budget impact analysis (BIA) is an economic assessment that estimates the financial consequences of adopting a new intervention. BIA is used to make informed reimbursement decisions, as a supplement to cost-effectiveness analyses (CEAs).Objectives: We systematically reviewed BIA studies associated with anti-diabetic drugs and assessed the extent to which international BIA guidelines were followed in these studies.Methods: We conducted a literature search on PubMed, Web of Science, Econlit, Medline, China National Knowledge Infrastructure (CNKI), Wanfang Data knowledge Service platform from database inception to June 30, 2021. ISPOR good practice guidelines were used as a methodological standard for assessing BIAs. We extracted and compared the study characteristics outlined by the ISPOR BIA Task Force to evaluate the guideline compliance of the included BIA.Results: A total of eighteen studies on the BIA for anti-diabetic drugs were identified. More than half studies were from developed countries. Seventeen studies were based on model and one study was based on real-world data. Overall, analysis considered a payer perspective, reported potential budget impacts over 1–5 years. Assumptions were mainly made about target population size, market share uptake of new interventions, and scope of cost. The data used for analysis varied among studies and was rarely justified. Model validation and sensitivity analysis were lacking in the current BIA studies. Rebate analysis was conducted in a few studies to explore the price discount that was required for new interventions to demonstrate cost equivalence to comparators.Conclusion: Existing studies evaluating budget impact for anti-diabetic drugs vary greatly in methodology, some of which showed low compliance to good practice guidelines. In order for the BIA to be useful for assisting in health plan decision-making, it is important for future studies to optimize compliance to national or ISPOR good practice guidelines on BIA. Model validation and sensitivity analysis should also be improved in future BIA studies. Continued improvement of BIA using real-world data is necessary to ensure high-quality analyses and to provide reliable results.Zejun LuoZhen RuanDongning YaoCarolina Oi Lam UngCarolina Oi Lam UngYunfeng LaiYunfeng LaiHao HuHao HuFrontiers Media S.A.articlebudget impact analysisdiabetescost-effectivenessBIACEAPublic aspects of medicineRA1-1270ENFrontiers in Public Health, Vol 9 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	budget impact analysis diabetes cost-effectiveness BIA CEA Public aspects of medicine RA1-1270
spellingShingle	budget impact analysis diabetes cost-effectiveness BIA CEA Public aspects of medicine RA1-1270 Zejun Luo Zhen Ruan Dongning Yao Carolina Oi Lam Ung Carolina Oi Lam Ung Yunfeng Lai Yunfeng Lai Hao Hu Hao Hu Budget Impact Analysis of Diabetes Drugs: A Systematic Literature Review
description	Background: Budget impact analysis (BIA) is an economic assessment that estimates the financial consequences of adopting a new intervention. BIA is used to make informed reimbursement decisions, as a supplement to cost-effectiveness analyses (CEAs).Objectives: We systematically reviewed BIA studies associated with anti-diabetic drugs and assessed the extent to which international BIA guidelines were followed in these studies.Methods: We conducted a literature search on PubMed, Web of Science, Econlit, Medline, China National Knowledge Infrastructure (CNKI), Wanfang Data knowledge Service platform from database inception to June 30, 2021. ISPOR good practice guidelines were used as a methodological standard for assessing BIAs. We extracted and compared the study characteristics outlined by the ISPOR BIA Task Force to evaluate the guideline compliance of the included BIA.Results: A total of eighteen studies on the BIA for anti-diabetic drugs were identified. More than half studies were from developed countries. Seventeen studies were based on model and one study was based on real-world data. Overall, analysis considered a payer perspective, reported potential budget impacts over 1–5 years. Assumptions were mainly made about target population size, market share uptake of new interventions, and scope of cost. The data used for analysis varied among studies and was rarely justified. Model validation and sensitivity analysis were lacking in the current BIA studies. Rebate analysis was conducted in a few studies to explore the price discount that was required for new interventions to demonstrate cost equivalence to comparators.Conclusion: Existing studies evaluating budget impact for anti-diabetic drugs vary greatly in methodology, some of which showed low compliance to good practice guidelines. In order for the BIA to be useful for assisting in health plan decision-making, it is important for future studies to optimize compliance to national or ISPOR good practice guidelines on BIA. Model validation and sensitivity analysis should also be improved in future BIA studies. Continued improvement of BIA using real-world data is necessary to ensure high-quality analyses and to provide reliable results.
format	article
author	Zejun Luo Zhen Ruan Dongning Yao Carolina Oi Lam Ung Carolina Oi Lam Ung Yunfeng Lai Yunfeng Lai Hao Hu Hao Hu
author_facet	Zejun Luo Zhen Ruan Dongning Yao Carolina Oi Lam Ung Carolina Oi Lam Ung Yunfeng Lai Yunfeng Lai Hao Hu Hao Hu
author_sort	Zejun Luo
title	Budget Impact Analysis of Diabetes Drugs: A Systematic Literature Review
title_short	Budget Impact Analysis of Diabetes Drugs: A Systematic Literature Review
title_full	Budget Impact Analysis of Diabetes Drugs: A Systematic Literature Review
title_fullStr	Budget Impact Analysis of Diabetes Drugs: A Systematic Literature Review
title_full_unstemmed	Budget Impact Analysis of Diabetes Drugs: A Systematic Literature Review
title_sort	budget impact analysis of diabetes drugs: a systematic literature review
publisher	Frontiers Media S.A.
publishDate	2021
url	https://doaj.org/article/a0af68f6f1624bf5ba2cdb9e929b7fb9
work_keys_str_mv	AT zejunluo budgetimpactanalysisofdiabetesdrugsasystematicliteraturereview AT zhenruan budgetimpactanalysisofdiabetesdrugsasystematicliteraturereview AT dongningyao budgetimpactanalysisofdiabetesdrugsasystematicliteraturereview AT carolinaoilamung budgetimpactanalysisofdiabetesdrugsasystematicliteraturereview AT carolinaoilamung budgetimpactanalysisofdiabetesdrugsasystematicliteraturereview AT yunfenglai budgetimpactanalysisofdiabetesdrugsasystematicliteraturereview AT yunfenglai budgetimpactanalysisofdiabetesdrugsasystematicliteraturereview AT haohu budgetimpactanalysisofdiabetesdrugsasystematicliteraturereview AT haohu budgetimpactanalysisofdiabetesdrugsasystematicliteraturereview
_version_	1718420391541604352

Budget Impact Analysis of Diabetes Drugs: A Systematic Literature Review

Ejemplares similares